Anavex Life Sciences Corp (AVXL)

[Talon38]

The evolving new blood evaluation for Alzheimer's may trigger a much larger number of actual and potential people with the disease. It will lead to possible millions who will take 2-73 as a simple pill for the disease or prophylactically for prevention. The noninvasive pill form of our drug with no significant side effects will deal quickly with a significant increase in the number of actual/potential Alzheimer's patients! All we need will be a very large and worldwide partner who can produce/distribute/sell our drug. Think we will see that partner appear when we apply for a new drug status with the EMA.